[HTML][HTML] Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors

H Mehta, A Tufail, V Daien, AY Lee, V Nguyen… - Progress in retinal and …, 2018 - Elsevier
Clinical trials identified intravitreal vascular endothelial growth factor inhibitors (anti-VEGF
agents) have the potential to stabilise or even improve visual acuity outcomes in …

Amblyopia preferred practice pattern®

DK Wallace, MX Repka, KA Lee, M Melia… - …, 2018 - aaojournal.org
Amblyopia is a unilateral or, less often, bilateral reduction of best-corrected visual acuity
(BCVA) that usually occurs in the setting of an otherwise normal eye. It is a developmental …

Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab

CR Baumal, RF Spaide, L Vajzovic, KB Freund… - Ophthalmology, 2020 - Elsevier
Purpose To evaluate features and outcomes of eyes with retinal vasculitis and intraocular
inflammation (IOI) after intravitreal injection (IVI) of brolucizumab 6 mg/0.05 ml for treatment …

[HTML][HTML] Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b/2 trial

SR Russell, AV Drack, AV Cideciyan, SG Jacobson… - Nature medicine, 2022 - nature.com
CEP290-associated Leber congenital amaurosis type 10 (LCA10) is a retinal disease
resulting in childhood blindness. Sepofarsen is an RNA antisense oligonucleotide targeting …

The Study of Muscle, Mobility and Aging (SOMMA): a unique cohort study about the cellular biology of aging and age-related loss of mobility

SR Cummings, AB Newman, PM Coen… - The Journals of …, 2023 - academic.oup.com
Abstract Background The Study of Muscle, Mobility and Aging (SOMMA) aims to understand
the biological basis of many facets of human aging, with a focus on mobility decline, by …

[HTML][HTML] Neurodevelopmental disorders in children aged 2–9 years: Population-based burden estimates across five regions in India

NK Arora, MKC Nair, S Gulati, V Deshmukh… - PLoS …, 2018 - journals.plos.org
Background Neurodevelopmental disorders (NDDs) compromise the development and
attainment of full social and economic potential at individual, family, community, and country …

[HTML][HTML] Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

U Chakravarthy, SP Harding, CA Rogers, SM Downes… - The Lancet, 2013 - thelancet.com
Background Bevacizumab has been suggested to have similar effectiveness to ranibizumab
for treatment of neovascular age-related macular degeneration. The Inhibition of VEGF in …

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial

U Chakravarthy, SP Harding, CA Rogers, SM Downes… - Ophthalmology, 2012 - Elsevier
PURPOSE: To compare the efficacy and safety of ranibizumab and bevacizumab intravitreal
injections to treat neovascular age-related macular degeneration (nAMD). DESIGN …

Development and validation of a smartphone-based visual acuity test (peek acuity) for clinical practice and community-based fieldwork

A Bastawrous, HK Rono, IAT Livingstone… - JAMA …, 2015 - jamanetwork.com
Importance Visual acuity is the most frequently performed measure of visual function in
clinical practice and most people worldwide living with visual impairment are living in low …

Risk factors for hip fracture in white women

SR Cummings, MC Nevitt, WS Browner… - New England journal …, 1995 - Mass Medical Soc
Background Many risk factors for hip fractures have been suggested but have not been
evaluated in a comprehensive prospective study. Methods We assessed potential risk …